238 related articles for article (PubMed ID: 38295557)
1. Biomarkers of mitochondrial disorders.
Shayota BJ
Neurotherapeutics; 2024 Jan; 21(1):e00325. PubMed ID: 38295557
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
[TBL] [Abstract][Full Text] [Related]
3. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.
Peñas A; Fernández-De la Torre M; Laine-Menéndez S; Lora D; Illescas M; García-Bartolomé A; Morales-Conejo M; Arenas J; Martín MA; Morán M; Domínguez-González C; Ugalde C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203775
[TBL] [Abstract][Full Text] [Related]
4. Expanding and validating the biomarkers for mitochondrial diseases.
Maresca A; Del Dotto V; Romagnoli M; La Morgia C; Di Vito L; Capristo M; Valentino ML; Carelli V;
J Mol Med (Berl); 2020 Oct; 98(10):1467-1478. PubMed ID: 32851462
[TBL] [Abstract][Full Text] [Related]
5. FGF-21 as a Potential Biomarker for Mitochondrial Diseases.
Scholle LM; Lehmann D; Deschauer M; Kraya T; Zierz S
Curr Med Chem; 2018; 25(18):2070-2081. PubMed ID: 29332568
[TBL] [Abstract][Full Text] [Related]
6. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
Davis RL; Liang C; Sue CM
Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
[TBL] [Abstract][Full Text] [Related]
7. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine.
Burow P; Haselier M; Naegel S; Scholle LM; Gaul C; Kraya T
Cells; 2021 Sep; 10(9):. PubMed ID: 34572118
[TBL] [Abstract][Full Text] [Related]
8. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H
Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for mitochondrial energy metabolism diseases.
Boenzi S; Diodato D
Essays Biochem; 2018 Jul; 62(3):443-454. PubMed ID: 29980631
[TBL] [Abstract][Full Text] [Related]
10. Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders.
Tsygankova PG; Itkis YS; Krylova TD; Kurkina MV; Bychkov IO; Ilyushkina AA; Zabnenkova VV; Mikhaylova SV; Pechatnikova NL; Sheremet NL; Zakharova EY
J Inherit Metab Dis; 2019 Sep; 42(5):918-933. PubMed ID: 31260105
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease.
Koga Y; Povalko N; Inoue E; Nashiki K; Tanaka M
Mitochondrion; 2019 Sep; 48():11-15. PubMed ID: 30738201
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial diseases.
Davis RL; Liang C; Sue CM
Handb Clin Neurol; 2018; 147():125-141. PubMed ID: 29325608
[TBL] [Abstract][Full Text] [Related]
13. Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders.
Huddar A; Govindaraj P; Chiplunkar S; Deepha S; Jessiena Ponmalar JN; Philip M; Nagappa M; Narayanappa G; Mahadevan A; Sinha S; Taly AB; Parayil Sankaran B
Mitochondrion; 2021 Sep; 60():170-177. PubMed ID: 34419687
[TBL] [Abstract][Full Text] [Related]
14. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
[TBL] [Abstract][Full Text] [Related]
15. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases.
Fujita Y; Ito M; Kojima T; Yatsuga S; Koga Y; Tanaka M
Mitochondrion; 2015 Jan; 20():34-42. PubMed ID: 25446397
[TBL] [Abstract][Full Text] [Related]
16. Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases.
Trifunov S; Paredes-Fuentes AJ; Badosa C; Codina A; Montoya J; Ruiz-Pesini E; Jou C; Garrabou G; Grau-Junyent JM; Yubero D; Montero R; Muchart J; Ortigoza-Escobar JD; O'Callaghan MM; Nascimento A; Català A; Garcia-Cazorla À; Jimenez-Mallebrera C; Artuch R
Clin Chem; 2021 Aug; 67(8):1113-1121. PubMed ID: 34352085
[TBL] [Abstract][Full Text] [Related]
17. Potential Biomarkers of Mitochondrial Dysfunction Associated with COVID-19 Infection.
Turton N; Millichap L; Hargreaves IP
Adv Exp Med Biol; 2023; 1412():211-224. PubMed ID: 37378769
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites.
Clarke C; Xiao R; Place E; Zhang Z; Sondheimer N; Bennett M; Yudkoff M; Falk MJ
Mol Genet Metab; 2013; 110(1-2):145-52. PubMed ID: 23920046
[TBL] [Abstract][Full Text] [Related]
19. Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report.
Fukuda M; Nagao Y
J Med Case Rep; 2019 Oct; 13(1):313. PubMed ID: 31630688
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: A meta-analysis.
Lin Y; Ji K; Ma X; Liu S; Li W; Zhao Y; Yan C
Ann Clin Transl Neurol; 2020 Jul; 7(7):1204-1213. PubMed ID: 32585080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
